• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk modeling for ventricular assist device support in post-cardiotomy shock.心脏术后休克患者心室辅助装置支持的风险建模
J Saudi Heart Assoc. 2012 Apr;24(2):69-72. doi: 10.1016/j.jsha.2012.02.005. Epub 2012 Feb 13.
2
Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score.采用新评分法计算心脏手术中主动脉内球囊反搏植入后的预后。
Circulation. 2002 Sep 24;106(12 Suppl 1):I203-6.
3
Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.接受直接经皮冠状动脉介入治疗和主动脉内球囊反搏的心源性休克患者的死亡率预测因素。
Med Klin Intensivmed Notfmed. 2016 Nov;111(8):715-722. doi: 10.1007/s00063-015-0118-8. Epub 2015 Nov 23.
4
[A clinical study of preoperative prophylactic application of intra-aortic balloon pump in extreme high-risk patients undergoing coronary artery bypass grafting].主动脉内球囊反搏术前预防性应用于极高危冠状动脉旁路移植术患者的临床研究
Zhonghua Wai Ke Za Zhi. 2013 Sep;51(9):808-11.
5
Beneficial effect of preventative intra-aortic balloon pumping in high-risk patients undergoing first-time coronary artery bypass grafting-a single center experience.高危患者首次冠状动脉旁路移植术中预防性主动脉内球囊反搏的有益效果:单中心经验。
Artif Organs. 2009 Aug;33(8):587-92. doi: 10.1111/j.1525-1594.2009.00788.x. Epub 2009 Jun 28.
6
Intra-aortic balloon pump in coronary artery bypass graft - factors affecting outcome.冠状动脉搭桥术中的主动脉内球囊反搏——影响预后的因素
J West Afr Coll Surg. 2011 Oct;1(4):28-40.
7
Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP Support.心脏手术后右心室功能不全患者的主动脉内球囊反搏:预测主动脉内球囊反搏支持失败的参数
Thorac Cardiovasc Surg. 2009 Sep;57(6):324-8. doi: 10.1055/s-0029-1185766. Epub 2009 Aug 25.
8
Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery.主动脉内球囊反搏在心脏手术围术期心源性休克患者中的临床应用。
Exp Ther Med. 2017 May;13(5):1741-1748. doi: 10.3892/etm.2017.4177. Epub 2017 Mar 2.
9
Preoperative Use of Intra-Aortic Balloon Pump Support Reduced 30-Day Mortality in a Population with LVEF >35% and High Surgical Risk after Coronary Artery Bypass Graft Surgery.冠状动脉旁路移植术后左心室射血分数>35%且手术风险高的人群中,术前使用主动脉内球囊泵支持可降低30天死亡率。
Cardiology. 2020;145(5):267-274. doi: 10.1159/000506393. Epub 2020 Mar 27.
10
Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG.术前主动脉内球囊反搏可增强心脏功能并改善再次冠状动脉旁路移植术的预后。
Ann Thorac Surg. 1997 Nov;64(5):1237-44. doi: 10.1016/S0003-4975(97)00898-9.

引用本文的文献

1
Mechanical support for high-risk coronary artery bypass grafting.高危冠状动脉搭桥手术的机械支持
Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):287-296. doi: 10.1007/s12055-018-0740-1. Epub 2018 Oct 23.
2
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock.心源性休克的临床与监管概况:心脏安全研究联盟智库关于心源性休克的报告
Am Heart J. 2020 Jan;219:1-8. doi: 10.1016/j.ahj.2019.10.006. Epub 2019 Nov 7.
3
Management of refractory cardiogenic shock.难治性心源性休克的治疗。
Nat Rev Cardiol. 2016 Aug;13(8):481-92. doi: 10.1038/nrcardio.2016.96. Epub 2016 Jun 30.
4
Message from the editor in chief.主编寄语。
J Saudi Heart Assoc. 2013 Jan;25(1):1-2. doi: 10.1016/j.jsha.2013.01.001.

本文引用的文献

1
Implantation of a left ventricular assist device and the hub-and-spoke system in treating acute cardiogenic shock: who survives?
J Thorac Cardiovasc Surg. 2003 Nov;126(5):1634-5. doi: 10.1016/s0022-5223(03)00727-x.
2
Revised screening scale to predict survival after insertion of a left ventricular assist device.
J Thorac Cardiovasc Surg. 2003 Apr;125(4):855-62. doi: 10.1067/mtc.2003.111.
3
Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score.采用新评分法计算心脏手术中主动脉内球囊反搏植入后的预后。
Circulation. 2002 Sep 24;106(12 Suppl 1):I203-6.
4
Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps?心脏术后衰竭的恢复桥梁:离心泵是否仍有作用?
Ann Thorac Surg. 2000 Oct;70(4):1259-63. doi: 10.1016/s0003-4975(00)01715-x.
5
Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system.心脏术后休克后植入心室辅助装置的药理学标准:Abiomed BVS系统的经验
J Card Surg. 1999 Jul-Aug;14(4):288-93. doi: 10.1111/j.1540-8191.1999.tb00996.x.
6
Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients.高危冠心病患者术前主动脉内球囊反搏支持的最佳时机
Ann Thorac Surg. 1999 Sep;68(3):934-9. doi: 10.1016/s0003-4975(99)00687-6.
7
Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock.体外膜肺氧合用于心脏术后心源性休克
Ann Thorac Surg. 1996 Feb;61(2):684-91. doi: 10.1016/0003-4975(95)01042-4.
8
Extracorporeal membrane oxygenation for adult post cardiotomy cardiogenic shock using a heparin bonded system.
ASAIO J. 1993 Jul-Sep;39(3):M444-7. doi: 10.1097/00002480-199307000-00058.
9
The intraaortic balloon pump for postcardiotomy heart failure. Experience with 169 intraaortic balloon pumps.用于心脏术后心力衰竭的主动脉内球囊反搏泵。169例主动脉内球囊反搏泵的应用经验。
Thorac Cardiovasc Surg. 1995 Jun;43(3):129-33. doi: 10.1055/s-2007-1013786.
10
Initial clinical experience with intraaortic balloon pumping in cardiogenic shock.主动脉内球囊反搏治疗心源性休克的初步临床经验。
JAMA. 1968 Jan 8;203(2):113-8.

心脏术后休克患者心室辅助装置支持的风险建模

Risk modeling for ventricular assist device support in post-cardiotomy shock.

作者信息

Alsoufi Bahaaldin, Rao Vivek, Tang Augustine, Maganti Manjula, Cusimano Robert

机构信息

Division of Cardiovascular Surgery, Toronto General Hospital and the University of Toronto, Toronto, Ontario, Canada.

出版信息

J Saudi Heart Assoc. 2012 Apr;24(2):69-72. doi: 10.1016/j.jsha.2012.02.005. Epub 2012 Feb 13.

DOI:10.1016/j.jsha.2012.02.005
PMID:23960674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3727495/
Abstract

BACKGROUND

Post-cardiotomy shock (PCS) has a complex etiology. Although treatment with inotrops and intra-aortic balloon pump (IABP) support improves cardiac performance, end-organ injuries are common and lead to prolonged ICU stay, extended hospitalization and increased mortality. Early consideration of mechanical circulatory support may prevent such complications and improve outcome.

METHODS

Between January 1997 and January 2002, 321 patients required IABP and inotropic support for PCS following coronary artery bypass grafting (CABG) at our institution. Perioperative variables including age, mixed venous saturation (MVO2), inotropic requirements and LV function were analyzed using multivariate statistical methods. All explanatory variables with a univariate p value <0.10 were entered into a stepwise logistic regression model to predict hospital mortality. Odds ratios from significant variables (p < 0.05) in the regression model were used to compose a risk score.

RESULTS

Overall hospital mortality was 16%. The independent risk factors for mortality in this population were: MVO2 < 60% (OR = 3.2), milrinone > 0.5 μg/kg/min (OR = 3.2), age > 75 (OR = 2.7), adrenaline > 0.1 μg/kg/min (OR = 1.5). A 15-point risk score was developed based on the regression model. Hospital mortality in patients with a score >6 was 46% (n = 13/28), 3-6 was 31% (n = 9/29) and <3 was 11% (n = 29/264).

CONCLUSIONS

A significant proportion of patients with PCS continue to face high mortality despite IABP and inotropic support. Advanced age, heavy inotropic dependency and poor oxygen delivery all predicted increased risk for death. Further investigation is needed to assess whether early institution of VAD support could improve outcome in this high-risk group of patients.

摘要

背景

心脏术后休克(PCS)病因复杂。尽管使用血管活性药物和主动脉内球囊反搏(IABP)支持治疗可改善心脏功能,但多器官损伤常见,会导致重症监护病房(ICU)住院时间延长、住院时间延长及死亡率增加。早期考虑机械循环支持可能预防此类并发症并改善预后。

方法

1997年1月至2002年1月期间,我院321例冠状动脉旁路移植术(CABG)后因PCS需要IABP和血管活性药物支持的患者。使用多变量统计方法分析围手术期变量,包括年龄、混合静脉血氧饱和度(MVO2)、血管活性药物需求和左心室功能。将所有单变量p值<0.10的解释变量纳入逐步逻辑回归模型以预测医院死亡率。回归模型中显著变量(p<0.05)的比值比用于构成风险评分。

结果

总体医院死亡率为16%。该人群死亡的独立危险因素为:MVO2<60%(比值比=3.2)、米力农>0.5μg/kg/min(比值比=3.2)、年龄>75岁(比值比=2.7)、肾上腺素>0.1μg/kg/min(比值比=1.5)。基于回归模型制定了一个15分的风险评分。评分>6分的患者医院死亡率为46%(n=13/28),3-6分的为31%(n=9/29),<3分的为11%(n=29/264)。

结论

尽管有IABP和血管活性药物支持,仍有相当比例的PCS患者面临高死亡率。高龄、对血管活性药物高度依赖和氧输送不足均预示死亡风险增加。需要进一步研究以评估早期应用心室辅助装置(VAD)支持是否能改善这一高危患者群体的预后。